Industry Research Reports

Home > Reports > Chemical & Material > Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Global Hirudin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Industry: Chemical & Material

Published Date: 2024-04-17

Pages: 154 Pages

Report ld: 2699410

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hirudin Market Size(US$)

CAGR 2024-2030

3.1%

Market Size,2030

USD 4,934.7

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 4,108.7 million

Market Forecast in 2030(Value)

US$ 4,934.7 million

CAGR

3.1%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

The global Hirudin market size was US$ 3975 million in 2023 and is forecast to a readjusted size of US$ 4934.7 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

In terms of production side, this report researches the Hirudin capacity, production, growth rate, market share by manufacturers, region level and country level, from 2019 to 2024, and forecast to 2030.

In terms of sales (consumption) side, this report focuses on the sales of Hirudin by region (Countries), company, type and application. from 2019 to 2024 and forecast to 2030.

The global Hirudin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by type segment of the global Hirudin market. These figures have been provided in terms of both revenue and volume for the period 2019-2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

MARKET SEGMENTATION

By Company

The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Natural Hirudin
Recombinant Hirudin

Segment by Application

Thrombosis Disease
Tumor Disease
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Hirudin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Hirudin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by company, by type, by application and by country, sales, and revenue for each segment.

Chapter 8: Europe by company, by type, by application and by country, sales, and revenue for each segment.

Chapter 9: China by company, by type and by application, sales, and revenue for each segment.

Chapter 10: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hirudin sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Hirudin Definition

1.2 Market by Type

1.2.1 Global Hirudin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Natural Hirudin

1.2.3 Recombinant Hirudin

1.3 Market by Application

1.3.1 Global Hirudin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Thrombosis Disease

1.3.3 Tumor Disease

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Hirudin Sales

2.1 Global Hirudin Revenue Estimates and Forecasts 2019-2030

2.2 Global Hirudin Revenue by Region: 2019 VS 2023 VS 2030

2.3 Global Hirudin Revenue by Region

2.3.1 Global Hirudin Revenue by Region (2019-2024)

2.3.2 Global Hirudin Revenue by Region (2025-2030)

2.4 Global Hirudin Sales Quantity Estimates and Forecasts 2019-2030

2.5 Global Hirudin Sales Quantity by Region: 2019 VS 2023 VS 2030

2.6 Global Hirudin Sales Quantity by Region

2.6.1 Global Hirudin Sales Quantity by Region (2019-2024)

2.6.2 Global Hirudin Sales Quantity by Region (2025-2030)

2.7 North America

2.8 Europe

2.9 China

2.10 APAC (excluding China)

2.11 Middle East, Africa and Latin America

3 Global Production (Based on Production Site)

3.1 Global Hirudin Production Value by Region: 2019 VS 2023 VS 2030

3.2 Global Hirudin Production Value by Region

3.2.1 Global Hirudin Historic Production Value by Region (2019-2024)

3.2.2 Global Hirudin Forecasted Production Value by Region (2025-2030)

3.3 Global Hirudin Production Capacity (2019-2030)

3.4 Global Hirudin Production by Region: 2019 VS 2023 VS 2030

3.5 Global Hirudin Production by Region

3.5.1 Global Hirudin Historic Production by Region (2019-2024)

3.5.2 Global Hirudin Forecasted Production by Region (2025-2030)

3.5.3 North America

3.5.4 Europe

3.5.5 Japan

3.5.6 China

3.5.7 South Korea

3.5.8 India

4 Competition by Manufacturers

4.1 Global Hirudin Sales Quantity by Manufacturers

4.1.1 Global Hirudin Sales Quantity by Manufacturers (2019-2024)

4.1.2 Global Hirudin Sales Quantity Share by Manufacturers (2019-2024)

4.1.3 Global Top 10 and Top 5 Companies by Hirudin Sales in 2023

4.2 Global Hirudin Revenue by Manufacturers

4.2.1 Global Hirudin Revenue by Manufacturers (2019-2024)

4.2.2 Global Hirudin Revenue Share by Manufacturers (2019-2024)

4.2.3 Global Top 10 and Top 5 Companies by Hirudin Revenue in 2023

4.3 Global Hirudin Sales Price by Manufacturers

4.4 Global Key Players of Hirudin, Industry Ranking, 2022 VS 2023

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Hirudin, Product Offered and Application

4.8 Global Key Manufacturers of Hirudin, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Estimates and Forecasts by Type

5.1 Global Hirudin Sales Quantity by Type

5.1.1 Global Hirudin Historical Sales Quantity by Type (2019-2024)

5.1.2 Global Hirudin Forecasted Sales Quantity by Type (2025-2030)

5.1.3 Global Hirudin Sales Quantity Market Share by Type (2019-2030)

5.2 Global Hirudin Revenue by Type

5.2.1 Global Hirudin Historical Revenue by Type (2019-2024)

5.2.2 Global Hirudin Forecasted Revenue by Type (2025-2030)

5.2.3 Global Hirudin Revenue Market Share by Type (2019-2030)

5.3 Global Hirudin Price by Type

5.3.1 Global Hirudin Price by Type (2019-2024)

5.3.2 Global Hirudin Price Forecast by Type (2025-2030)

6 Market Size by Application

6.1 Global Hirudin Sales Quantity by Application

6.1.1 Global Hirudin Historical Sales Quantity by Application (2019-2024)

6.1.2 Global Hirudin Forecasted Sales Quantity by Application (2025-2030)

6.1.3 Global Hirudin Sales Quantity Market Share by Application (2019-2030)

6.2 Global Hirudin Revenue by Application

6.2.1 Global Hirudin Historical Revenue by Application (2019-2024)

6.2.2 Global Hirudin Forecasted Revenue by Application (2025-2030)

6.2.3 Global Hirudin Revenue Market Share by Application (2019-2030)

6.3 Global Hirudin Price by Application

6.3.1 Global Hirudin Price by Application (2019-2024)

6.3.2 Global Hirudin Price Forecast by Application (2025-2030)

7 North America

7.1 North America Hirudin Sales by Company

7.1.1 North America Hirudin Revenue by Company (2019-2024)

7.1.2 North America Hirudin Sales Quantity by Company (2019-2024)

7.2 North America Hirudin Market Size by Type

7.2.1 North America Hirudin Sales Quantity by Type (2019-2030)

7.2.2 North America Hirudin Revenue by Type (2019-2030)

7.3 North America Hirudin Market Size by Application

7.3.1 North America Hirudin Sales Quantity by Application (2019-2030)

7.3.2 North America Hirudin Revenue by Application (2019-2030)

7.4 North America Hirudin Market Size by Country

7.4.1 North America Hirudin Revenue by Country: 2019 VS 2023 VS 2030

7.4.2 North America Hirudin Revenue by Country (2019-2030)

7.4.3 North America Hirudin Sales Quantity by Country (2019-2030)

7.4.4 U.S.

7.4.5 Canada

8 Europe

8.1 Europe Hirudin Sales by Company

8.1.1 Europe Hirudin Sales Quantity by Company (2019-2024)

8.1.2 Europe Hirudin Revenue by Company (2019-2024)

8.2 Europe Hirudin Market Size by Type

8.2.1 Europe Hirudin Sales Quantity by Type (2019-2030)

8.2.2 Europe Hirudin Revenue by Type (2019-2030)

8.3 Europe Hirudin Market Size by Application

8.3.1 Europe Hirudin Sales Quantity by Application (2019-2030)

8.3.2 Europe Hirudin Revenue by Application (2019-2030)

8.4 Europe Hirudin Market Size by Country

8.4.1 Europe Hirudin Revenue by Country: 2019 VS 2023 VS 2030

8.4.2 Europe Hirudin Revenue by Country (2019-2030)

8.4.3 Europe Hirudin Sales Quantity by Country (2019-2030)

8.4.4 Germany

8.4.5 France

8.4.6 U.K.

8.4.7 Italy

8.4.8 Russia

9 China

9.1 China Hirudin Sales by Company

9.1.1 China Hirudin Sales Quantity by Company (2019-2024)

9.1.2 China Hirudin Revenue by Company (2019-2024)

9.2 China Hirudin Market Size by Type

9.2.1 China Hirudin Sales Quantity by Type (2019-2030)

9.2.2 China Hirudin Revenue by Type (2019-2030)

9.3 China Hirudin Market Size by Application

9.3.1 China Hirudin Sales Quantity by Application (2019-2030)

9.3.2 China Hirudin Revenue by Application (2019-2030)

10 APAC (excluding China)

10.1 APAC Hirudin Sales by Company

10.1.1 APAC Hirudin Sales Quantity by Company (2019-2024)

10.1.2 APAC Hirudin Revenue by Company (2019-2024)

10.2 APAC Hirudin Market Size by Type

10.2.1 APAC Hirudin Sales Quantity by Type (2019-2030)

10.2.2 APAC Hirudin Revenue by Type (2019-2030)

10.3 APAC Hirudin Market Size by Application

10.3.1 APAC Hirudin Sales Quantity by Application (2019-2030)

10.3.2 APAC Hirudin Revenue by Application (2019-2030)

10.4 APAC Hirudin Market Size by Region

10.4.1 APAC Hirudin Revenue by Region: 2019 VS 2023 VS 2030

10.4.2 APAC Hirudin Revenue by Region (2019-2030)

10.4.3 APAC Hirudin Sales Quantity by Region (2019-2030)

10.4.4 Japan

10.4.5 South Korea

10.4.6 China Taiwan

10.4.7 Southeast Asia

10.4.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America Hirudin Sales by Company

11.1.1 Middle East, Africa and Latin America Hirudin Sales Quantity by Company (2019-2024)

11.1.2 Middle East, Africa and Latin America Hirudin Revenue by Company (2019-2024)

11.2 Middle East, Africa and Latin America Hirudin Market Size by Type

11.2.1 Middle East, Africa and Latin America Hirudin Sales Quantity by Type (2019-2030)

11.2.2 Middle East, Africa and Latin America Hirudin Revenue by Type (2019-2030)

11.3 Middle East, Africa and Latin America Hirudin Market Size by Application

11.3.1 Middle East, Africa and Latin America Hirudin Sales Quantity by Application (2019-2030)

11.3.2 Middle East, Africa and Latin America Hirudin Revenue by Application (2019-2030)

11.4 Middle East, Africa and Latin America Hirudin Market Size by Country

11.4.1 Middle East, Africa and Latin America Hirudin Revenue by Country: 2019 VS 2023 VS 2030

11.4.2 Middle East, Africa and Latin America Hirudin Revenue by Country (2019-2030)

11.4.3 Middle East, Africa and Latin America Hirudin Sales Quantity by Country (2019-2030)

11.4.4 Brazil

11.4.5 Mexico

11.4.6 Turkey

11.4.7 Israel

11.4.8 GCC Countries

12 Company Profiles

12.1 The Medicines Company

12.1.1 The Medicines Company Company Information

12.1.2 The Medicines Company Overview

12.1.3 The Medicines Company Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.1.4 The Medicines Company Hirudin Products and Services

12.1.5 The Medicines Company Hirudin SWOT Analysis

12.1.6 The Medicines Company Recent Developments

12.2 Keyken

12.2.1 Keyken Company Information

12.2.2 Keyken Overview

12.2.3 Keyken Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.2.4 Keyken Hirudin Products and Services

12.2.5 Keyken Hirudin SWOT Analysis

12.2.6 Keyken Recent Developments

12.3 Minapharm

12.3.1 Minapharm Company Information

12.3.2 Minapharm Overview

12.3.3 Minapharm Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.3.4 Minapharm Hirudin Products and Services

12.3.5 Minapharm Hirudin SWOT Analysis

12.3.6 Minapharm Recent Developments

12.4 Abbott

12.4.1 Abbott Company Information

12.4.2 Abbott Overview

12.4.3 Abbott Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.4.4 Abbott Hirudin Products and Services

12.4.5 Abbott Hirudin SWOT Analysis

12.4.6 Abbott Recent Developments

12.5 SALUBRIS

12.5.1 SALUBRIS Company Information

12.5.2 SALUBRIS Overview

12.5.3 SALUBRIS Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.5.4 SALUBRIS Hirudin Products and Services

12.5.5 SALUBRIS Hirudin SWOT Analysis

12.5.6 SALUBRIS Recent Developments

12.6 Pfizer, Inc

12.6.1 Pfizer, Inc Company Information

12.6.2 Pfizer, Inc Overview

12.6.3 Pfizer, Inc Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.6.4 Pfizer, Inc Hirudin Products and Services

12.6.5 Pfizer, Inc Hirudin SWOT Analysis

12.6.6 Pfizer, Inc Recent Developments

12.7 Teva Pharmaceutical Industries Ltd

12.7.1 Teva Pharmaceutical Industries Ltd Company Information

12.7.2 Teva Pharmaceutical Industries Ltd Overview

12.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.7.4 Teva Pharmaceutical Industries Ltd Hirudin Products and Services

12.7.5 Teva Pharmaceutical Industries Ltd Hirudin SWOT Analysis

12.7.6 Teva Pharmaceutical Industries Ltd Recent Developments

12.8 DUOPUTAI

12.8.1 DUOPUTAI Company Information

12.8.2 DUOPUTAI Overview

12.8.3 DUOPUTAI Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.8.4 DUOPUTAI Hirudin Products and Services

12.8.5 DUOPUTAI Hirudin SWOT Analysis

12.8.6 DUOPUTAI Recent Developments

12.9 Pentapharm

12.9.1 Pentapharm Company Information

12.9.2 Pentapharm Overview

12.9.3 Pentapharm Hirudin Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.9.4 Pentapharm Hirudin Products and Services

12.9.5 Pentapharm Hirudin SWOT Analysis

12.9.6 Pentapharm Recent Developments

13 Value Chain and Sales Channels Analysis

13.1 Hirudin Value Chain Analysis

13.2 Hirudin Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Hirudin Production Mode & Process

13.4 Hirudin Sales and Marketing

13.4.1 Hirudin Sales Channels

13.4.2 Hirudin Distributors

13.5 Hirudin Customers

14 Market Dynamics

14.1 Hirudin Industry Trends

14.2 Hirudin Market Drivers

14.3 Hirudin Market Challenges

14.4 Hirudin Market Restraints

15 Key Findings

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Hirudin Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Natural Hirudin

Table 3. Major Manufacturers of Recombinant Hirudin

Table 4. Global Hirudin Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Hirudin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Hirudin Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Hirudin Revenue Market Share by Region (2019-2024)

Table 8. Global Hirudin Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Hirudin Revenue Market Share by Region (2025-2030)

Table 10. Global Hirudin Sales Quantity by Region: 2019 VS 2023 VS 2030 (K MT)

Table 11. Global Hirudin Sales by Region (2019-2024) & (K MT)

Table 12. Global Hirudin Sales Market Share by Region (2019-2024)

Table 13. Global Hirudin Sales by Region (2025-2030) & (K MT)

Table 14. Global Hirudin Sales Market Share by Region (2025-2030)

Table 15. Global Hirudin Production Value Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Hirudin Production Value by Region (2019-2024) & (US$ Million)

Table 17. Global Hirudin Production Value Market Share by Region (2019-2024)

Table 18. Global Hirudin Production Value by Region (2025-2030) & (US$ Million)

Table 19. Global Hirudin Production Value Market Share by Region (2025-2030)

Table 20. Global Hirudin Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K MT)

Table 21. Global Hirudin Production by Region (2019-2024) & (K MT)

Table 22. Global Hirudin Production Market Share by Region (2019-2024)

Table 23. Global Hirudin Production by Region (2025-2030) & (K MT)

Table 24. Global Hirudin Production Market Share by Region (2025-2030)

Table 25. Global Hirudin Sales Quantity by Manufacturers (2019-2024) & (K MT)

Table 26. Global Hirudin Sales Quantity Share by Manufacturers (2019-2024)

Table 27. Global Hirudin Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 28. Global Hirudin Revenue Share by Manufacturers (2019-2024)

Table 29. Global Hirudin Price by Manufacturers 2019-2024 (USD/MT)

Table 30. Global Key Players of Hirudin, Industry Ranking, 2022 VS 2023

Table 31. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 32. Global Hirudin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hirudin as of 2023)

Table 33. Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters

Table 34. Global Key Manufacturers of Hirudin, Product Offered and Application

Table 35. Global Key Manufacturers of Hirudin, Date of Enter into This Industry

Table 36. Mergers & Acquisitions, Expansion Plans

Table 37. Global Hirudin Sales Quantity by Type (2019-2024) & (K MT)

Table 38. Global Hirudin Sales Quantity by Type (2025-2030) & (K MT)

Table 39. Global Hirudin Sales Quantity Share by Type (2019-2024)

Table 40. Global Hirudin Sales Quantity Share by Type (2025-2030)

Table 41. Global Hirudin Revenue by Type (2019-2024) & (US$ Million)

Table 42. Global Hirudin Revenue by Type (2025-2030) & (US$ Million)

Table 43. Global Hirudin Revenue Share by Type (2019-2024)

Table 44. Global Hirudin Revenue Share by Type (2025-2030)

Table 45. Hirudin Price by Type (2019-2024) & (USD/MT)

Table 46. Global Hirudin Price Forecast by Type (2025-2030) & (USD/MT)

Table 47. Global Hirudin Sales Quantity by Application (2019-2024) & (K MT)

Table 48. Global Hirudin Sales Quantity by Application (2025-2030) & (K MT)

Table 49. Global Hirudin Sales Quantity Share by Application (2019-2024)

Table 50. Global Hirudin Sales Quantity Share by Application (2025-2030)

Table 51. Global Hirudin Revenue by Application (2019-2024) & (US$ Million)

Table 52. Global Hirudin Revenue by Application (2025-2030) & (US$ Million)

Table 53. Global Hirudin Revenue Share by Application (2019-2024)

Table 54. Global Hirudin Revenue Share by Application (2025-2030)

Table 55. Hirudin Price by Application (2019-2024) & (USD/MT)

Table 56. Global Hirudin Price Forecast by Application (2025-2030) & (USD/MT)

Table 57. North America Hirudin Revenue by Company (2019-2024) & (US$ Million)

Table 58. North America Hirudin Sales Quantity by Company (2019-2024) & (K MT)

Table 59. North America Hirudin Sales Quantity by Type (2019-2024) & (K MT)

Table 60. North America Hirudin Sales Quantity by Type (2025-2030) & (K MT)

Table 61. North America Hirudin Revenue by Type (2019-2024) & (US$ Million)

Table 62. North America Hirudin Revenue by Type (2025-2030) & (US$ Million)

Table 63. North America Hirudin Sales Quantity by Application (2019-2024) & (K MT)

Table 64. North America Hirudin Sales Quantity by Application (2025-2030) & (K MT)

Table 65. North America Hirudin Revenue by Application (2019-2024) & (US$ Million)

Table 66. North America Hirudin Revenue by Application (2025-2030) & (US$ Million)

Table 67. North America Hirudin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 68. North America Hirudin Revenue by Country (2019-2024) & (US$ Million)

Table 69. North America Hirudin Revenue by Country (2025-2030) & (US$ Million)

Table 70. North America Hirudin Sales Quantity by Country (2019-2024) & (K MT)

Table 71. North America Hirudin Sales Quantity by Country (2025-2030) & (K MT)

Table 72. Europe Hirudin Sales Quantity by Company (2019-2024) & (K MT)

Table 73. Europe Hirudin Revenue by Company (2019-2024) & (US$ Million)

Table 74. Europe Hirudin Sales Quantity by Type (2019-2024) & (K MT)

Table 75. Europe Hirudin Sales Quantity by Type (2025-2030) & (K MT)

Table 76. Europe Hirudin Revenue by Type (2019-2024) & (US$ Million)

Table 77. Europe Hirudin Revenue by Type (2025-2030) & (US$ Million)

Table 78. Europe Hirudin Sales Quantity by Application (2019-2024) & (K MT)

Table 79. Europe Hirudin Sales Quantity by Application (2025-2030) & (K MT)

Table 80. Europe Hirudin Revenue by Application (2019-2024) & (US$ Million)

Table 81. Europe Hirudin Revenue by Application (2025-2030) & (US$ Million)

Table 82. Europe Hirudin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 83. Europe Hirudin Revenue by Country (2019-2024) & (US$ Million)

Table 84. Europe Hirudin Revenue by Country (2025-2030) & (US$ Million)

Table 85. Europe Hirudin Sales Quantity by Country (2019-2024) & (K MT)

Table 86. Europe Hirudin Sales Quantity by Country (2025-2030) & (K MT)

Table 87. China Hirudin Sales Quantity by Company (2019-2024) & (K MT)

Table 88. China Hirudin Revenue by Company (2019-2024) & (US$ Million)

Table 89. China Hirudin Sales Quantity by Type (2019-2024) & (K MT)

Table 90. China Hirudin Sales Quantity by Type (2025-2030) & (K MT)

Table 91. China Hirudin Revenue by Type (2019-2024) & (US$ Million)

Table 92. China Hirudin Revenue by Type (2025-2030) & (US$ Million)

Table 93. China Hirudin Sales Quantity by Application (2019-2024) & (K MT)

Table 94. China Hirudin Sales Quantity by Application (2025-2030) & (K MT)

Table 95. China Hirudin Revenue by Application (2019-2024) & (US$ Million)

Table 96. China Hirudin Revenue by Application (2025-2030) & (US$ Million)

Table 97. APAC Hirudin Sales Quantity by Company (2019-2024) & (K MT)

Table 98. APAC Hirudin Revenue by Company (2019-2024) & (US$ Million)

Table 99. APAC Hirudin Sales Quantity by Type (2019-2024) & (K MT)

Table 100. APAC Hirudin Sales Quantity by Type (2025-2030) & (K MT)

Table 101. APAC Hirudin Revenue by Type (2019-2024) & (US$ Million)

Table 102. APAC Hirudin Revenue by Type (2025-2030) & (US$ Million)

Table 103. APAC Hirudin Sales Quantity by Application (2019-2024) & (K MT)

Table 104. APAC Hirudin Sales Quantity by Application (2025-2030) & (K MT)

Table 105. APAC Hirudin Revenue by Application (2019-2024) & (US$ Million)

Table 106. APAC Hirudin Revenue by Application (2025-2030) & (US$ Million)

Table 107. APAC Hirudin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 108. APAC Hirudin Revenue by Region (2019-2024) & (US$ Million)

Table 109. APAC Hirudin Revenue by Region (2025-2030) & (US$ Million)

Table 110. APAC Hirudin Sales Quantity by Region (2019-2024) & (K MT)

Table 111. APAC Hirudin Sales Quantity by Region (2025-2030) & (K MT)

Table 112. Middle East, Africa and Latin America Hirudin Sales Quantity by Company (2019-2024) & (K MT)

Table 113. Middle East, Africa and Latin America Hirudin Revenue by Company (2019-2024) & (US$ Million)

Table 114. Middle East, Africa and Latin America Hirudin Sales Quantity by Type (2019-2024) & (K MT)

Table 115. Middle East, Africa and Latin America Hirudin Sales Quantity by Type (2025-2030) & (K MT)

Table 116. Middle East, Africa and Latin America Hirudin Revenue by Type (2019-2024) & (US$ Million)

Table 117. Middle East, Africa and Latin America Hirudin Revenue by Type (2025-2030) & (US$ Million)

Table 118. Middle East, Africa and Latin America Hirudin Sales Quantity by Application (2019-2024) & (K MT)

Table 119. Middle East, Africa and Latin America Hirudin Sales Quantity by Application (2025-2030) & (K MT)

Table 120. Middle East, Africa and Latin America Hirudin Revenue by Application (2019-2024) & (US$ Million)

Table 121. Middle East, Africa and Latin America Hirudin Revenue by Application (2025-2030) & (US$ Million)

Table 122. Middle East, Africa and Latin America Hirudin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 123. Middle East, Africa and Latin America Hirudin Revenue by Country (2019-2024) & (US$ Million)

Table 124. Middle East, Africa and Latin America Hirudin Revenue by Country (2025-2030) & (US$ Million)

Table 125. Middle East, Africa and Latin America Hirudin Sales Quantity by Country (2019-2024) & (K MT)

Table 126. Middle East, Africa and Latin America Hirudin Sales Quantity by Country (2025-2030) & (K MT)

Table 127. The Medicines Company Company Information

Table 128. The Medicines Company Description and Overview

Table 129. The Medicines Company Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 130. The Medicines Company Hirudin Products and Services

Table 131. The Medicines Company Hirudin SWOT Analysis

Table 132. The Medicines Company Recent Development

Table 133. Keyken Company Information

Table 134. Keyken Description and Overview

Table 135. Keyken Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 136. Keyken Hirudin Products and Services

Table 137. Keyken Hirudin SWOT Analysis

Table 138. Keyken Recent Development

Table 139. Minapharm Company Information

Table 140. Minapharm Description and Overview

Table 141. Minapharm Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 142. Minapharm Hirudin Products and Services

Table 143. Minapharm Hirudin SWOT Analysis

Table 144. Minapharm Recent Development

Table 145. Abbott Company Information

Table 146. Abbott Description and Overview

Table 147. Abbott Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 148. Abbott Hirudin Products and Services

Table 149. Abbott Hirudin SWOT Analysis

Table 150. Abbott Recent Development

Table 151. SALUBRIS Company Information

Table 152. SALUBRIS Description and Overview

Table 153. SALUBRIS Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 154. SALUBRIS Hirudin Products and Services

Table 155. SALUBRIS Hirudin SWOT Analysis

Table 156. SALUBRIS Recent Development

Table 157. Pfizer, Inc Company Information

Table 158. Pfizer, Inc Description and Overview

Table 159. Pfizer, Inc Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 160. Pfizer, Inc Hirudin Products and Services

Table 161. Pfizer, Inc Hirudin SWOT Analysis

Table 162. Pfizer, Inc Recent Development

Table 163. Teva Pharmaceutical Industries Ltd Company Information

Table 164. Teva Pharmaceutical Industries Ltd Description and Overview

Table 165. Teva Pharmaceutical Industries Ltd Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 166. Teva Pharmaceutical Industries Ltd Hirudin Products and Services

Table 167. Teva Pharmaceutical Industries Ltd Hirudin SWOT Analysis

Table 168. Teva Pharmaceutical Industries Ltd Recent Development

Table 169. DUOPUTAI Company Information

Table 170. DUOPUTAI Description and Overview

Table 171. DUOPUTAI Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 172. DUOPUTAI Hirudin Products and Services

Table 173. DUOPUTAI Hirudin SWOT Analysis

Table 174. DUOPUTAI Recent Development

Table 175. Pentapharm Company Information

Table 176. Pentapharm Description and Overview

Table 177. Pentapharm Hirudin Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2019-2024)

Table 178. Pentapharm Hirudin Products and Services

Table 179. Pentapharm Hirudin SWOT Analysis

Table 180. Pentapharm Recent Development

Table 181. Key Raw Materials Lists

Table 182. Raw Materials Key Suppliers Lists

Table 183. Hirudin Distributors List

Table 184. Hirudin Customers List

Table 185. Hirudin Market Trends

Table 186. Hirudin Market Drivers

Table 187. Hirudin Market Challenges

Table 188. Hirudin Market Restraints

Table 189. Research Programs/Design for This Report

Table 190. Key Data Information from Secondary Sources

Table 191. Key Data Information from Primary Sources

List of Figures

Figure 1. Hirudin Product Picture

Figure 2. Global Hirudin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Hirudin Market Share by Type in 2023 & 2030

Figure 4. Natural Hirudin Product Picture

Figure 5. Recombinant Hirudin Product Picture

Figure 6. Global Hirudin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Hirudin Market Share by Application in 2023 & 2030

Figure 8. Thrombosis Disease

Figure 9. Tumor Disease

Figure 10. Others

Figure 11. Hirudin Report Years Considered

Figure 12. Global Hirudin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Hirudin Revenue 2019-2030 (US$ Million)

Figure 14. Global Hirudin Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Hirudin Sales Quantity 2019-2030 (K MT)

Figure 16. Global Hirudin Sales Quantity Market Share by Region (2019-2024)

Figure 17. Global Hirudin Sales Quantity Market Share by Region (2025-2030)

Figure 18. North America Hirudin Sales Quantity YoY (2019-2030) & (K MT)

Figure 19. North America Hirudin Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Hirudin Sales Quantity YoY (2019-2030) & (K MT)

Figure 21. Europe Hirudin Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Hirudin Sales Quantity YoY (2019-2030) & (K MT)

Figure 23. China Hirudin Revenue YoY (2019-2030) & (US$ Million)

Figure 24. APAC Hirudin Sales Quantity YoY (2019-2030) & (K MT)

Figure 25. APAC Hirudin Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Hirudin Sales Quantity YoY (2019-2030) & (K MT)

Figure 27. Middle East, Africa and Latin America Hirudin Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Global Hirudin Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 29. Global Hirudin Production Value Market Share by Region in Percentage: 2023 Versus 2030

Figure 30. Global Hirudin Capacity, Production and Utilization (2019-2030) & (K MT)

Figure 31. Global Hirudin Production by Region: 2019 VS 2023 VS 2030 (K MT)

Figure 32. Global Hirudin Production Market Share by Region in Percentage: 2023 Versus 2030

Figure 33. Hirudin Production Growth Rate in North America (2019-2030) & (K MT)

Figure 34. Hirudin Production Growth Rate in Europe (2019-2030) & (K MT)

Figure 35. Hirudin Production Growth Rate in Japan (2019-2030) & (K MT)

Figure 36. Hirudin Production Growth Rate in China (2019-2030) & (K MT)

Figure 37. Hirudin Production Growth Rate in South Korea (2019-2030) & (K MT)

Figure 38. Hirudin Production Growth Rate in India (2019-2030) & (K MT)

Figure 39. The Top 10 and Top 5 Players Market Share by Hirudin Sales Quantity in 2023

Figure 40. The Top 10 and Top 5 Players Market Share by Hirudin Revenue in 2023

Figure 41. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 42. Global Hirudin Sales Quantity Market Share by Type (2019-2030)

Figure 43. Global Hirudin Revenue Market Share by Type (2019-2030)

Figure 44. Global Hirudin Sales Quantity Market Share by Application (2019-2030)

Figure 45. Global Hirudin Revenue Market Share by Application (2019-2030)

Figure 46. North America Hirudin Revenue Market Share by Company in 2023

Figure 47. North America Hirudin Sales Quantity Market Share by Company in 2023

Figure 48. North America Hirudin Sales Quantity Market Share by Type (2019-2030)

Figure 49. North America Hirudin Revenue Market Share by Type (2019-2030)

Figure 50. North America Hirudin Sales Quantity Market Share by Application (2019-2030)

Figure 51. North America Hirudin Revenue Market Share by Application (2019-2030)

Figure 52. North America Hirudin Revenue Share by Country (2019-2030)

Figure 53. North America Hirudin Sales Quantity Share by Country (2019-2030)

Figure 54. U.S. Hirudin Revenue (2019-2030) & (US$ Million)

Figure 55. Canada Hirudin Revenue (2019-2030) & (US$ Million)

Figure 56. Europe Hirudin Sales Quantity Market Share by Company in 2023

Figure 57. Europe Hirudin Revenue Market Share by Company in 2023

Figure 58. Europe Hirudin Sales Quantity Market Share by Type (2019-2030)

Figure 59. Europe Hirudin Revenue Market Share by Type (2019-2030)

Figure 60. Europe Hirudin Sales Quantity Market Share by Application (2019-2030)

Figure 61. Europe Hirudin Revenue Market Share by Application (2019-2030)

Figure 62. Europe Hirudin Revenue Share by Country (2019-2030)

Figure 63. Europe Hirudin Sales Quantity Share by Country (2019-2030)

Figure 64. Germany Hirudin Revenue (2019-2030) & (US$ Million)

Figure 65. France Hirudin Revenue (2019-2030) & (US$ Million)

Figure 66. U.K. Hirudin Revenue (2019-2030) & (US$ Million)

Figure 67. Italy Hirudin Revenue (2019-2030) & (US$ Million)

Figure 68. Russia Hirudin Revenue (2019-2030) & (US$ Million)

Figure 69. China Hirudin Sales Quantity Market Share by Company in 2023

Figure 70. China Hirudin Revenue Market Share by Company in 2023

Figure 71. China Hirudin Sales Quantity Market Share by Type (2019-2030)

Figure 72. China Hirudin Revenue Market Share by Type (2019-2030)

Figure 73. China Hirudin Sales Quantity Market Share by Application (2019-2030)

Figure 74. China Hirudin Revenue Market Share by Application (2019-2030)

Figure 75. APAC Hirudin Sales Quantity Market Share by Company in 2023

Figure 76. APAC Hirudin Revenue Market Share by Company in 2023

Figure 77. APAC Hirudin Sales Quantity Market Share by Type (2019-2030)

Figure 78. APAC Hirudin Revenue Market Share by Type (2019-2030)

Figure 79. APAC Hirudin Sales Quantity Market Share by Application (2019-2030)

Figure 80. APAC Hirudin Revenue Market Share by Application (2019-2030)

Figure 81. APAC Hirudin Revenue Share by Region (2019-2030)

Figure 82. APAC Hirudin Sales Quantity Share by Region (2019-2030)

Figure 83. Japan Hirudin Revenue (2019-2030) & (US$ Million)

Figure 84. South Korea Hirudin Revenue (2019-2030) & (US$ Million)

Figure 85. China Taiwan Hirudin Revenue (2019-2030) & (US$ Million)

Figure 86. Southeast Asia Hirudin Revenue (2019-2030) & (US$ Million)

Figure 87. India Hirudin Revenue (2019-2030) & (US$ Million)

Figure 88. Middle East, Africa and Latin America Hirudin Sales Quantity Market Share by Company in 2023

Figure 89. Middle East, Africa and Latin America Hirudin Revenue Market Share by Company in 2023

Figure 90. Middle East, Africa and Latin America Hirudin Sales Quantity Market Share by Type (2019-2030)

Figure 91. Middle East, Africa and Latin America Hirudin Revenue Market Share by Type (2019-2030)

Figure 92. Middle East, Africa and Latin America Hirudin Sales Quantity Market Share by Application (2019-2030)

Figure 93. Middle East, Africa and Latin America Hirudin Revenue Market Share by Application (2019-2030)

Figure 94. Middle East, Africa and Latin America Hirudin Sales Quantity Share by Country (2019-2030)

Figure 95. Middle East, Africa and Latin America Hirudin Revenue Share by Country (2019-2030)

Figure 96. Brazil Hirudin Revenue (2019-2030) & (US$ Million)

Figure 97. Mexico Hirudin Revenue (2019-2030) & (US$ Million)

Figure 98. Turkey Hirudin Revenue (2019-2030) & (US$ Million)

Figure 99. Israel Hirudin Revenue (2019-2030) & (US$ Million)

Figure 100. GCC Countries Hirudin Revenue (2019-2030) & (US$ Million)

Figure 101. Hirudin Value Chain

Figure 102. Hirudin Production Process

Figure 103. Channels of Distribution (Direct Vs Distribution)

Figure 104. Distributors Profiles

Figure 105. Bottom-up and Top-down Approaches for This Report

Figure 106. Data Triangulation

Figure 107. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Hirudin in 2030? shouQi

What was the global market size of Hirudin in 2024? shouQi

What is the annual compound growth rate of the global Hirudin market size from 2024 to 2030? shouQi

Which companies rank high in the global Hirudin market? shouQi

Related Reports

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 150
USD 2900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 3950.00
(Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 180
USD 4900.00
(Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 142
USD 3950.00
(Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 180
USD 4900.00
(Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-06-11
Pages: 106
USD 4250.00
(Single User License)
Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-06-11
Pages: 114
USD 2900.00
(Single User License)
Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 97
USD 3950.00
(Single User License)

Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hirudin market size was US$ 4341 million in 2025 and is forecast to reach a readjusted size of US$ 5359 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
Global Hirudin Market Research Report 2026
The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 150
USD 2900.00 (Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hirudin was estimated to be worth US$ 4341 million in 2025 and is projected to reach US$ 5359 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
USD 3950.00 (Single User License)
Global Hirudin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hirudin market is projected to grow from US$ 4223 million in 2024 to US$ 5214 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 180
USD 4900.00 (Single User License)
Hirudin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 142
USD 3950.00 (Single User License)
Global Hirudin Market Insights, Forecast to 2031
The global Hirudin market is projected to grow from US$ 4341 million in 2025 to US$ 5214 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 180
USD 4900.00 (Single User License)
Global Hirudin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hirudin market size was US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-06-11
Pages: 106
USD 4250.00 (Single User License)
Global Hirudin Market Research Report 2025
The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-06-11
Pages: 114
USD 2900.00 (Single User License)
Global Hirudin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hirudin was estimated to be worth US$ 4223 million and is forecast to reach approximately US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)
Hirudin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hirudin was estimated to be worth US$ 4223 million in 2024 and is forecast to a readjusted size of US$ 5214 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 97
USD 3950.00 (Single User License)